Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
| Actual shortage: | 237 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2778 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-NAPROXEN EC TABLETS | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2020-12-18 | 2021-01-19 | 130410 |
| APO-MELOXICAM | 7.5MG | TABLET | Resolved | 2020-12-18 | 2021-01-26 | 130407 |
| APO-LAMOTRIGINE | 150MG | TABLET | Resolved | 2020-12-18 | 2021-02-01 | 130404 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2020-12-18 | 2021-03-15 | 130401 |
| APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2020-12-11 | 2021-01-11 | 130065 |
| APO-LAMOTRIGINE | 100MG | TABLET TABLET | Resolved | 2020-12-11 | 2021-02-01 | 130045 |
| APO-DEFERASIROX (TYPE J) | 360MG | TABLET | Resolved | 2020-12-11 | 2021-01-20 | 130040 |
| APO-CITALOPRAM | 20MG | TABLET | Resolved | 2020-12-11 | 2021-03-15 | 130037 |
| APO-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2020-12-04 | 2021-06-14 | 129608 |
| APO-FLUCONAZOLE | 100MG | TABLET TABLET | Resolved | 2020-12-04 | 2021-02-09 | 129601 |
| APO-CETIRIZINE | 10MG | TABLET | Resolved | 2020-12-04 | 2020-12-11 | 129598 |
| APO-ENALAPRIL | 2.5MG | TABLET | Resolved | 2020-11-26 | 2021-03-09 | 128942 |
| APO-GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-11-26 | 2020-12-17 | 128933 |
| APO-FLUCONAZOLE | 50MG | TABLET TABLET | Resolved | 2020-11-26 | 2021-02-09 | 128928 |
| APO-ELETRIPTAN | 20MG | TABLET TABLET | Resolved | 2020-11-26 | 2022-06-03 | 128925 |
| APO-ALENDRONATE/VITAMIN D3 | 70MG 5600UNIT | TABLET | Resolved | 2020-11-26 | 2021-04-15 | 128922 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Resolved | 2020-11-19 | 2020-12-28 | 128629 |
| APO-SOTALOL | 80MG | TABLET | Resolved | 2020-11-19 | 2021-02-09 | 128626 |
| APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2020-11-19 | 2020-12-21 | 128621 |
| APO-QUETIAPINE | 100MG | TABLET | Resolved | 2020-11-19 | 2020-12-17 | 128618 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-METFORMIN | 500MG | TABLET | Discontinued | 2018-02-23 | 2018-11-26 | 40790 |
| APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40784 |
| APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40781 |
| APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
| DOCUSATE SODIUM CAPSULES | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2018-09-15 | 40738 |
| APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
| APO-TERAZOSIN | 2MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |
| APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
| APO-OLANZAPINE | 5.0MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4968 |
| APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
| APO-SOTALOL | 80MG | TABLET | Discontinued | 2017-03-31 | 2018-12-07 | 4936 |
| APO-LOPERAMIDE | 2MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4930 |
| APO-GEMFIBROZIL | 600MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4927 |
| APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |